Schizophrenia is a major neuropsychiatric disorder that affects 2% of the population worldwide. No biochemical diagnostic tests are available, and patients must undergo lengthy clinical evaluation periods before an accurate diagnosis can be given. Blood and cerebrospinal fluid are candidates for the identification of potential biomarkers for this disease. We have identified several N-glycans that distinguish first onset, unmedicated schizophrenia patients from healthy individuals. This is the...Expand abstract
- Publisher copy:
- Copyright date:
Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia.
If you are the owner of this record, you can report an update to it here: Report update to this record